About NDA Group
NDA Group is a company based in Upplands Vasby (Sweden) founded in 1997 was acquired by SSI Strategy in August 2023. NDA Group offers products and services including Regulatory Strategy Services, Agency Engagement Services, and Global Dossier Preparation. NDA Group operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.
- Headquarter Upplands Vasby, Sweden
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
SSI Strategy
(Aug 15, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NDA Group
NDA Group offers a comprehensive portfolio of products and services, including Regulatory Strategy Services, Agency Engagement Services, and Global Dossier Preparation.
Offers planning for drug approval processes and risk management.
Facilitates interactions with FDA and EMA for compliance.
Creates multi-jurisdictional dossiers for international approvals.
Funding Insights of NDA Group
Detailed funding history for NDA Group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in NDA Group
NDA Group has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SSI Strategy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmacovigilance and medical affairs services are offered for drug development.
|
Locked | Locked | Locked |
Investor details for NDA Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NDA Group
Investment portfolio details for NDA Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NDA Group
Detailed financials for NDA Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nda Group Comparisons
Peer comparison for NDA Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NDA Group
NDA Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
Detailed competitors of NDA Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nda Group
Complete news archive for NDA Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NDA Group
NDA Group was founded in 1997.
NDA Group is headquartered in Upplands Vasby, Sweden. It is registered at Upplands Vasby, Stockholm County, Sweden.
NDA Group offers drug development consultancy services for life science for the development and commercialization of medical therapies. They have over 150 dedicated consultants with industry and regulatory backgrounds and also a support network of over 1000 scientific, clinical, regulatory and drug development experts. The company claims to have supported 40 of the new medicinal products that were approved in the EU during 2013-2016. They offer their services right from preclinical stage to the post marketing stage and encompass all regulated areas such as regulatory assessment, pharmacovigilance, quality assurance and health technology assessment (HTA). The company merged with PharmApprove, a scientific communications firm based out of the US in 2016. Their clientele includes top 10 pharma companies, mid-size and small pharma companies, among others.
NDA Group's top competitors include Indegene, Zuellig Pharma and IntegriChain.
NDA Group offers Regulatory Strategy Services, Agency Engagement Services, and Global Dossier Preparation.
NDA Group has 1 investor. Key investors include SSI Strategy.